AccScience Publishing / GPD / Online First / DOI: 10.36922/gpd.1320
Submit to GPD
Cite this article
49
Download
1461
Views
Journal Browser
Volume | Year
Issue
Search
Forthcoming Issue
Current Issue
View All
News and Announcements
View All
CASE REPORT

Multisystem inflammatory syndrome in adult with longitudinally extensive transverse myelitis following SARS-CoV-2 vaccination: A case report

Anirban Gupta1* ,  Sudheer Pandey1 ,  Pawan Dhull1 ,  Amit Sreen1 ,  Satish Barki1 ,  Krishna Kumar2 ,  Kompella Kiran Kumar3
Show Less
1 Department of Neurology, Army hospital (R&R), New Delhi, India
2 Department of Anesthesia and Critical Care, Army hospital (R&R), New Delhi, India
3 Department of Internal Medicine, Army hospital (R&R), New Delhi, India
GPD 2023, 2(3), 1320 https://doi.org/10.36922/gpd.1320
Submitted: 18 July 2023 | Accepted: 5 September 2023 | Published: 29 September 2023
© 2023 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Download PDF
Cite
XML
Abstract

Multisystem inflammatory syndrome in adults (MIS-A) is a known complication arising after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or vaccination. However, longitudinal extensive transverse myelitis (LETM), which is a neurological manifestation of MIS-A, is rarely reported among individuals after SARS-CoV-2 infection or vaccination. Here, we present a case of a 38-year-old female, with a history of SARS-CoV-2 infection in May 2021 and subsequent SARS-CoV-2 vaccination (on November 1, 2021; COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine), who presented with acute flaccid quadriparesis with bowel and bladder involvement since December 26, 2021. While being treated in the hospital, she developed fever, rash, shock, myocarditis, breathlessness, jaundice, and acute kidney injury. Magnetic resonance Imaging revealed LETM. She was negative for SARS-CoV-2 infection and showed raised in SARS-CoV-2 antibody titer. Thus, she was diagnosed as having MIS-A with LETM and managed with Intravenous Immunoglobulin, antibiotics, hemodialysis, and steroids with improvement.

Keywords
Severe acute respiratory syndrome coronavirus 2
Multisystem inflammatory syndrome in adults
Vaccination
Flaccid quadriparesis
Longitudinal extensive transverse myelitis
Funding
None.
Conflict of interest
The authors declare they have no competing interests.
References
  1. Riphagen S, Gomez X, Gonzalez-Martinez C, et al., 2020, Hyperinflammatory shock in children during COVID-19 pandemic. Lancet, 395(10237): 1607–1608. https://doi.org/10.1016/S0140-6736(20)31094-1

 

  1. Verdoni L, Mazza A, Gervasoni A, et al., 2020, An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: An observational cohort study. Lancet, 395(10239): 1771–1778. https://doi.org/10.1016/S0140-6736(20)31103-X

 

  1. Morris SB, Schwartz NG, Patel P, et al., 2020, Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection-United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep, 69(40): 1450–1456. https://doi.org/10.15585/mmwr.mm6940e1

 

  1. Das S, Kar SS, Samanta S, et al., 2022, Immunogenic and reactogenic efficacy of Covaxin and Covishield: A comparative review. Immunol Res, 70(3): 289–315. https://doi.org/10.1007/s12026-022-09265-0

 

  1. Garg RK, Paliwal V, Malhotra HS, et al., 2023, Spectrum of serious neurological and psychiatric adverse events in Indian COVID-19 vaccine recipients: A systematic review of case reports and case series. Neurol India, 71: 209–227. https://doi.org/10.4103/0028-3886.375420

 

  1. Uwaydah AK, Hassan NM, Abu Ghoush MS, et al., 2021, Adult multisystem inflammatory syndrome in a patient who recovered from COVID-19 postvaccination. BMJ Case Rep, 14(4): e242060. https://doi.org/10.1136/bcr-2021-242060

 

  1. Salzman MB, Huang CW, O’Brien CM, et al., 2021, Multisystem inflammatory syndrome after SARS-CoV-2 infection and COVID-19 vaccination. Emerg Infect Dis, 27(7): 1944–1948. https://doi.org/10.3201/eid2707.210594

 

  1. Gao JJ, Tseng HP, Lin CL, et al., 2021, Acute transverse myelitis following Covid-19 vaccination. Vaccines (Basel), 9(9): 1008. https://doi.org/10.3390/vaccines9091008

 

  1. Pagenkopf C, Südmeyer M, 2021, A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. J Neuroimmunol, 358: 577606. https://doi.org/10.1016/j.jneuroim.2021.577606

 

  1. Pourmoghaddas Z, Sadeghizadeh A, Tara SZ, et al., 2021, Longitudinally extensive transverse myelitis as a sign of multisystem inflammatory syndrome following COVID-19 infection: A pediatric case report. J Neuroimmunol, 360: 577704. https://doi.org/10.1016/j.jneuroim.2021.577704

 

  1. Ismail II, Salama S, 2022, A systematic review of cases of CNS demyelination following COVID-19 vaccination. J Neuroimmunol, 362: 577765. https://doi.org/10.1016/j.jneuroim.2021.577765

 

  1. Tan WY, Khan AH, Yaakob MN, et al., 2021, Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: A case report. BMC Neurol, 21(1): 395. https://doi.org/10.1186/s12883-021-02427-x

 

  1. Notghi AA, Atley J, Silva M, 2021, Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination. Clin Med (London), 21(5): e535–e538. https://doi.org/10.7861/clinmed.2021-0470

 

  1. Grome HN, Threlkeld M, Threlkeld S, et al., 2021, Fatal multisystem inflammatory syndrome in adult after SARS-COV-2 natural infection and Covid-19 vaccination. Emerg Infect Dis, 27(11): 2914–2918. https://doi.org/10.3201/eid2711.211612
Share
Back to top
Gene & Protein in Disease, Electronic ISSN: 2811-003X Published by AccScience Publishing
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept